Pharmaceutical giant Eli Lilly & Co. cited two circuit opinions this week as it defended the legality of its threat to halt the flow of discounted drugs under the 340B pricing program for safety net hospitals that won't submit claims data sought by the drugmaker. Here, Law360 takes a closer look at the cases and decisions Eli Lilly is relying on.
Nonprofit health system Ascension Health Alliance must divest several of its surgery center facilities in order to complete its proposed $3.9 billion acquisition of AmSurg LLC, the Federal Trade Commission said Tuesday.
A first-of-its-kind halt on new Medicare enrollment for hospice and home health providers is shaking up dealmaking in the growing industry. A tougher enforcement landscape calls for more diligence from buyers and sellers, and renewed efforts to avoid what is known as the 36-month rule.